Home Healthcare Pharmaceuticals Anti-Fungal Treatment Market

Anti-Fungal Treatment Market Size, Share & Trends Analysis Report By Drug Class (Azoles, Echinocandins, Polyenes, Allylamines, Pyrimidines), By Therapeutic Indication (Systemic, Candidiasis, Cryptococcosis, Prophylactic Use of Antifungals, Coccidioidomycosis), By Pathogens (Candida, Aspergillus, Cryptococcus, Coccidioides Immitis, Zygomycetes, Trichophyton), By End-Users (Hospitals and Clinics, Dermatology Clinics) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Debashree B | Format: | Report Code: SR3955DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Anti-Fungal Treatment Market, By Drug Class 2022-2034 (USD MILLION/ Units)
    1. Azoles
    2. Echinocandins
    3. Polyenes
    4. Allylamines
    5. Pyrimidines
  2. Anti-Fungal Treatment Market, By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
    1. Systemic
    2. Candidiasis
    3. Cryptococcosis
    4. Prophylactic Use of Antifungals
    5. Coccidioidomycosis
  3. Anti-Fungal Treatment Market, By Pathogens 2022-2034 (USD MILLION/ Units)
    1. Candida
    2. Aspergillus
    3. Cryptococcus
    4. Coccidioides Immitis
    5. Zygomycetes
    6. Trichophyton
  4. Anti-Fungal Treatment Market, By End-Users 2022-2034 (USD MILLION/ Units)
    1. Hospitals and Clinics
    2. Dermatology Clinics
  5. Regional Anti-Fungal Treatment Market
    1. North America
      1. North America Anti-Fungal Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
      2. North America Anti-Fungal Treatment Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Systemic
        2. Candidiasis
        3. Cryptococcosis
        4. Prophylactic Use of Antifungals
        5. Coccidioidomycosis
      3. North America Anti-Fungal Treatment Market By Pathogens 2022-2034 (USD MILLION/ Units)
        1. Candida
        2. Aspergillus
        3. Cryptococcus
        4. Coccidioides Immitis
        5. Zygomycetes
        6. Trichophyton
      4. North America Anti-Fungal Treatment Market By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Dermatology Clinics
      5. U.S. Anti-Fungal Treatment Market
        1. U.S. Anti-Fungal Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Azoles
          2. Echinocandins
          3. Polyenes
          4. Allylamines
          5. Pyrimidines
        2. U.S. Anti-Fungal Treatment Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Systemic
          2. Candidiasis
          3. Cryptococcosis
          4. Prophylactic Use of Antifungals
          5. Coccidioidomycosis
        3. U.S. Anti-Fungal Treatment Market By Pathogens 2022-2034 (USD MILLION/ Units)
          1. Candida
          2. Aspergillus
          3. Cryptococcus
          4. Coccidioides Immitis
          5. Zygomycetes
          6. Trichophyton
        4. U.S. Anti-Fungal Treatment Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Dermatology Clinics
      6. Canada Anti-Fungal Treatment Market
        1. Canada Anti-Fungal Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Azoles
          2. Echinocandins
          3. Polyenes
          4. Allylamines
          5. Pyrimidines
        2. Canada Anti-Fungal Treatment Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Systemic
          2. Candidiasis
          3. Cryptococcosis
          4. Prophylactic Use of Antifungals
          5. Coccidioidomycosis
        3. Canada Anti-Fungal Treatment Market By Pathogens 2022-2034 (USD MILLION/ Units)
          1. Candida
          2. Aspergillus
          3. Cryptococcus
          4. Coccidioides Immitis
          5. Zygomycetes
          6. Trichophyton
        4. Canada Anti-Fungal Treatment Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Dermatology Clinics
    2. Europe
      1. Europe Anti-Fungal Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
      2. Europe Anti-Fungal Treatment Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Systemic
        2. Candidiasis
        3. Cryptococcosis
        4. Prophylactic Use of Antifungals
        5. Coccidioidomycosis
      3. Europe Anti-Fungal Treatment Market By Pathogens 2022-2034 (USD MILLION/ Units)
        1. Candida
        2. Aspergillus
        3. Cryptococcus
        4. Coccidioides Immitis
        5. Zygomycetes
        6. Trichophyton
      4. Europe Anti-Fungal Treatment Market By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Dermatology Clinics
      5. U.K. Anti-Fungal Treatment Market
        1. U.K. Anti-Fungal Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Azoles
          2. Echinocandins
          3. Polyenes
          4. Allylamines
          5. Pyrimidines
        2. U.K. Anti-Fungal Treatment Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Systemic
          2. Candidiasis
          3. Cryptococcosis
          4. Prophylactic Use of Antifungals
          5. Coccidioidomycosis
        3. U.K. Anti-Fungal Treatment Market By Pathogens 2022-2034 (USD MILLION/ Units)
          1. Candida
          2. Aspergillus
          3. Cryptococcus
          4. Coccidioides Immitis
          5. Zygomycetes
          6. Trichophyton
        4. U.K. Anti-Fungal Treatment Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Dermatology Clinics
      6. Germany Anti-Fungal Treatment Market
        1. Germany Anti-Fungal Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Azoles
          2. Echinocandins
          3. Polyenes
          4. Allylamines
          5. Pyrimidines
        2. Germany Anti-Fungal Treatment Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Systemic
          2. Candidiasis
          3. Cryptococcosis
          4. Prophylactic Use of Antifungals
          5. Coccidioidomycosis
        3. Germany Anti-Fungal Treatment Market By Pathogens 2022-2034 (USD MILLION/ Units)
          1. Candida
          2. Aspergillus
          3. Cryptococcus
          4. Coccidioides Immitis
          5. Zygomycetes
          6. Trichophyton
        4. Germany Anti-Fungal Treatment Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Dermatology Clinics
      7. France Anti-Fungal Treatment Market
        1. France Anti-Fungal Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Azoles
          2. Echinocandins
          3. Polyenes
          4. Allylamines
          5. Pyrimidines
        2. France Anti-Fungal Treatment Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Systemic
          2. Candidiasis
          3. Cryptococcosis
          4. Prophylactic Use of Antifungals
          5. Coccidioidomycosis
        3. France Anti-Fungal Treatment Market By Pathogens 2022-2034 (USD MILLION/ Units)
          1. Candida
          2. Aspergillus
          3. Cryptococcus
          4. Coccidioides Immitis
          5. Zygomycetes
          6. Trichophyton
        4. France Anti-Fungal Treatment Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Dermatology Clinics
      8. Spain Anti-Fungal Treatment Market
        1. Spain Anti-Fungal Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Azoles
          2. Echinocandins
          3. Polyenes
          4. Allylamines
          5. Pyrimidines
        2. Spain Anti-Fungal Treatment Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Systemic
          2. Candidiasis
          3. Cryptococcosis
          4. Prophylactic Use of Antifungals
          5. Coccidioidomycosis
        3. Spain Anti-Fungal Treatment Market By Pathogens 2022-2034 (USD MILLION/ Units)
          1. Candida
          2. Aspergillus
          3. Cryptococcus
          4. Coccidioides Immitis
          5. Zygomycetes
          6. Trichophyton
        4. Spain Anti-Fungal Treatment Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Dermatology Clinics
      9. Italy Anti-Fungal Treatment Market
        1. Italy Anti-Fungal Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Azoles
          2. Echinocandins
          3. Polyenes
          4. Allylamines
          5. Pyrimidines
        2. Italy Anti-Fungal Treatment Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Systemic
          2. Candidiasis
          3. Cryptococcosis
          4. Prophylactic Use of Antifungals
          5. Coccidioidomycosis
        3. Italy Anti-Fungal Treatment Market By Pathogens 2022-2034 (USD MILLION/ Units)
          1. Candida
          2. Aspergillus
          3. Cryptococcus
          4. Coccidioides Immitis
          5. Zygomycetes
          6. Trichophyton
        4. Italy Anti-Fungal Treatment Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Dermatology Clinics
      10. Russia Anti-Fungal Treatment Market
        1. Russia Anti-Fungal Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Azoles
          2. Echinocandins
          3. Polyenes
          4. Allylamines
          5. Pyrimidines
        2. Russia Anti-Fungal Treatment Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Systemic
          2. Candidiasis
          3. Cryptococcosis
          4. Prophylactic Use of Antifungals
          5. Coccidioidomycosis
        3. Russia Anti-Fungal Treatment Market By Pathogens 2022-2034 (USD MILLION/ Units)
          1. Candida
          2. Aspergillus
          3. Cryptococcus
          4. Coccidioides Immitis
          5. Zygomycetes
          6. Trichophyton
        4. Russia Anti-Fungal Treatment Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Dermatology Clinics
      11. Nordic Anti-Fungal Treatment Market
        1. Nordic Anti-Fungal Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Azoles
          2. Echinocandins
          3. Polyenes
          4. Allylamines
          5. Pyrimidines
        2. Nordic Anti-Fungal Treatment Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Systemic
          2. Candidiasis
          3. Cryptococcosis
          4. Prophylactic Use of Antifungals
          5. Coccidioidomycosis
        3. Nordic Anti-Fungal Treatment Market By Pathogens 2022-2034 (USD MILLION/ Units)
          1. Candida
          2. Aspergillus
          3. Cryptococcus
          4. Coccidioides Immitis
          5. Zygomycetes
          6. Trichophyton
        4. Nordic Anti-Fungal Treatment Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Dermatology Clinics
      12. Benelux Anti-Fungal Treatment Market
        1. Benelux Anti-Fungal Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Azoles
          2. Echinocandins
          3. Polyenes
          4. Allylamines
          5. Pyrimidines
        2. Benelux Anti-Fungal Treatment Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Systemic
          2. Candidiasis
          3. Cryptococcosis
          4. Prophylactic Use of Antifungals
          5. Coccidioidomycosis
        3. Benelux Anti-Fungal Treatment Market By Pathogens 2022-2034 (USD MILLION/ Units)
          1. Candida
          2. Aspergillus
          3. Cryptococcus
          4. Coccidioides Immitis
          5. Zygomycetes
          6. Trichophyton
        4. Benelux Anti-Fungal Treatment Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Dermatology Clinics
      13. Rest of Europe Anti-Fungal Treatment Market
        1. Rest of Europe Anti-Fungal Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Azoles
          2. Echinocandins
          3. Polyenes
          4. Allylamines
          5. Pyrimidines
        2. Rest of Europe Anti-Fungal Treatment Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Systemic
          2. Candidiasis
          3. Cryptococcosis
          4. Prophylactic Use of Antifungals
          5. Coccidioidomycosis
        3. Rest of Europe Anti-Fungal Treatment Market By Pathogens 2022-2034 (USD MILLION/ Units)
          1. Candida
          2. Aspergillus
          3. Cryptococcus
          4. Coccidioides Immitis
          5. Zygomycetes
          6. Trichophyton
        4. Rest of Europe Anti-Fungal Treatment Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Dermatology Clinics
    3. APAC
      1. APAC Anti-Fungal Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
      2. APAC Anti-Fungal Treatment Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Systemic
        2. Candidiasis
        3. Cryptococcosis
        4. Prophylactic Use of Antifungals
        5. Coccidioidomycosis
      3. APAC Anti-Fungal Treatment Market By Pathogens 2022-2034 (USD MILLION/ Units)
        1. Candida
        2. Aspergillus
        3. Cryptococcus
        4. Coccidioides Immitis
        5. Zygomycetes
        6. Trichophyton
      4. APAC Anti-Fungal Treatment Market By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Dermatology Clinics
      5. China Anti-Fungal Treatment Market
        1. China Anti-Fungal Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Azoles
          2. Echinocandins
          3. Polyenes
          4. Allylamines
          5. Pyrimidines
        2. China Anti-Fungal Treatment Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Systemic
          2. Candidiasis
          3. Cryptococcosis
          4. Prophylactic Use of Antifungals
          5. Coccidioidomycosis
        3. China Anti-Fungal Treatment Market By Pathogens 2022-2034 (USD MILLION/ Units)
          1. Candida
          2. Aspergillus
          3. Cryptococcus
          4. Coccidioides Immitis
          5. Zygomycetes
          6. Trichophyton
        4. China Anti-Fungal Treatment Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Dermatology Clinics
      6. Korea Anti-Fungal Treatment Market
        1. Korea Anti-Fungal Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Azoles
          2. Echinocandins
          3. Polyenes
          4. Allylamines
          5. Pyrimidines
        2. Korea Anti-Fungal Treatment Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Systemic
          2. Candidiasis
          3. Cryptococcosis
          4. Prophylactic Use of Antifungals
          5. Coccidioidomycosis
        3. Korea Anti-Fungal Treatment Market By Pathogens 2022-2034 (USD MILLION/ Units)
          1. Candida
          2. Aspergillus
          3. Cryptococcus
          4. Coccidioides Immitis
          5. Zygomycetes
          6. Trichophyton
        4. Korea Anti-Fungal Treatment Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Dermatology Clinics
      7. Japan Anti-Fungal Treatment Market
        1. Japan Anti-Fungal Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Azoles
          2. Echinocandins
          3. Polyenes
          4. Allylamines
          5. Pyrimidines
        2. Japan Anti-Fungal Treatment Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Systemic
          2. Candidiasis
          3. Cryptococcosis
          4. Prophylactic Use of Antifungals
          5. Coccidioidomycosis
        3. Japan Anti-Fungal Treatment Market By Pathogens 2022-2034 (USD MILLION/ Units)
          1. Candida
          2. Aspergillus
          3. Cryptococcus
          4. Coccidioides Immitis
          5. Zygomycetes
          6. Trichophyton
        4. Japan Anti-Fungal Treatment Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Dermatology Clinics
      8. India Anti-Fungal Treatment Market
        1. India Anti-Fungal Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Azoles
          2. Echinocandins
          3. Polyenes
          4. Allylamines
          5. Pyrimidines
        2. India Anti-Fungal Treatment Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Systemic
          2. Candidiasis
          3. Cryptococcosis
          4. Prophylactic Use of Antifungals
          5. Coccidioidomycosis
        3. India Anti-Fungal Treatment Market By Pathogens 2022-2034 (USD MILLION/ Units)
          1. Candida
          2. Aspergillus
          3. Cryptococcus
          4. Coccidioides Immitis
          5. Zygomycetes
          6. Trichophyton
        4. India Anti-Fungal Treatment Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Dermatology Clinics
      9. Australia Anti-Fungal Treatment Market
        1. Australia Anti-Fungal Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Azoles
          2. Echinocandins
          3. Polyenes
          4. Allylamines
          5. Pyrimidines
        2. Australia Anti-Fungal Treatment Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Systemic
          2. Candidiasis
          3. Cryptococcosis
          4. Prophylactic Use of Antifungals
          5. Coccidioidomycosis
        3. Australia Anti-Fungal Treatment Market By Pathogens 2022-2034 (USD MILLION/ Units)
          1. Candida
          2. Aspergillus
          3. Cryptococcus
          4. Coccidioides Immitis
          5. Zygomycetes
          6. Trichophyton
        4. Australia Anti-Fungal Treatment Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Dermatology Clinics
      10. Taiwan Anti-Fungal Treatment Market
        1. Taiwan Anti-Fungal Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Azoles
          2. Echinocandins
          3. Polyenes
          4. Allylamines
          5. Pyrimidines
        2. Taiwan Anti-Fungal Treatment Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Systemic
          2. Candidiasis
          3. Cryptococcosis
          4. Prophylactic Use of Antifungals
          5. Coccidioidomycosis
        3. Taiwan Anti-Fungal Treatment Market By Pathogens 2022-2034 (USD MILLION/ Units)
          1. Candida
          2. Aspergillus
          3. Cryptococcus
          4. Coccidioides Immitis
          5. Zygomycetes
          6. Trichophyton
        4. Taiwan Anti-Fungal Treatment Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Dermatology Clinics
      11. South East Asia Anti-Fungal Treatment Market
        1. South East Asia Anti-Fungal Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Azoles
          2. Echinocandins
          3. Polyenes
          4. Allylamines
          5. Pyrimidines
        2. South East Asia Anti-Fungal Treatment Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Systemic
          2. Candidiasis
          3. Cryptococcosis
          4. Prophylactic Use of Antifungals
          5. Coccidioidomycosis
        3. South East Asia Anti-Fungal Treatment Market By Pathogens 2022-2034 (USD MILLION/ Units)
          1. Candida
          2. Aspergillus
          3. Cryptococcus
          4. Coccidioides Immitis
          5. Zygomycetes
          6. Trichophyton
        4. South East Asia Anti-Fungal Treatment Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Dermatology Clinics
      12. Rest of Asia-Pacific Anti-Fungal Treatment Market
        1. Rest of Asia-Pacific Anti-Fungal Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Azoles
          2. Echinocandins
          3. Polyenes
          4. Allylamines
          5. Pyrimidines
        2. Rest of Asia-Pacific Anti-Fungal Treatment Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Systemic
          2. Candidiasis
          3. Cryptococcosis
          4. Prophylactic Use of Antifungals
          5. Coccidioidomycosis
        3. Rest of Asia-Pacific Anti-Fungal Treatment Market By Pathogens 2022-2034 (USD MILLION/ Units)
          1. Candida
          2. Aspergillus
          3. Cryptococcus
          4. Coccidioides Immitis
          5. Zygomycetes
          6. Trichophyton
        4. Rest of Asia-Pacific Anti-Fungal Treatment Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Dermatology Clinics
    4. Middle East and Africa
      1. Middle East and Africa Anti-Fungal Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
      2. Middle East and Africa Anti-Fungal Treatment Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Systemic
        2. Candidiasis
        3. Cryptococcosis
        4. Prophylactic Use of Antifungals
        5. Coccidioidomycosis
      3. Middle East and Africa Anti-Fungal Treatment Market By Pathogens 2022-2034 (USD MILLION/ Units)
        1. Candida
        2. Aspergillus
        3. Cryptococcus
        4. Coccidioides Immitis
        5. Zygomycetes
        6. Trichophyton
      4. Middle East and Africa Anti-Fungal Treatment Market By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Dermatology Clinics
      5. UAE Anti-Fungal Treatment Market
        1. UAE Anti-Fungal Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Azoles
          2. Echinocandins
          3. Polyenes
          4. Allylamines
          5. Pyrimidines
        2. UAE Anti-Fungal Treatment Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Systemic
          2. Candidiasis
          3. Cryptococcosis
          4. Prophylactic Use of Antifungals
          5. Coccidioidomycosis
        3. UAE Anti-Fungal Treatment Market By Pathogens 2022-2034 (USD MILLION/ Units)
          1. Candida
          2. Aspergillus
          3. Cryptococcus
          4. Coccidioides Immitis
          5. Zygomycetes
          6. Trichophyton
        4. UAE Anti-Fungal Treatment Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Dermatology Clinics
      6. Turkey Anti-Fungal Treatment Market
        1. Turkey Anti-Fungal Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Azoles
          2. Echinocandins
          3. Polyenes
          4. Allylamines
          5. Pyrimidines
        2. Turkey Anti-Fungal Treatment Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Systemic
          2. Candidiasis
          3. Cryptococcosis
          4. Prophylactic Use of Antifungals
          5. Coccidioidomycosis
        3. Turkey Anti-Fungal Treatment Market By Pathogens 2022-2034 (USD MILLION/ Units)
          1. Candida
          2. Aspergillus
          3. Cryptococcus
          4. Coccidioides Immitis
          5. Zygomycetes
          6. Trichophyton
        4. Turkey Anti-Fungal Treatment Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Dermatology Clinics
      7. Saudi Arabia Anti-Fungal Treatment Market
        1. Saudi Arabia Anti-Fungal Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Azoles
          2. Echinocandins
          3. Polyenes
          4. Allylamines
          5. Pyrimidines
        2. Saudi Arabia Anti-Fungal Treatment Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Systemic
          2. Candidiasis
          3. Cryptococcosis
          4. Prophylactic Use of Antifungals
          5. Coccidioidomycosis
        3. Saudi Arabia Anti-Fungal Treatment Market By Pathogens 2022-2034 (USD MILLION/ Units)
          1. Candida
          2. Aspergillus
          3. Cryptococcus
          4. Coccidioides Immitis
          5. Zygomycetes
          6. Trichophyton
        4. Saudi Arabia Anti-Fungal Treatment Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Dermatology Clinics
      8. South Africa Anti-Fungal Treatment Market
        1. South Africa Anti-Fungal Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Azoles
          2. Echinocandins
          3. Polyenes
          4. Allylamines
          5. Pyrimidines
        2. South Africa Anti-Fungal Treatment Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Systemic
          2. Candidiasis
          3. Cryptococcosis
          4. Prophylactic Use of Antifungals
          5. Coccidioidomycosis
        3. South Africa Anti-Fungal Treatment Market By Pathogens 2022-2034 (USD MILLION/ Units)
          1. Candida
          2. Aspergillus
          3. Cryptococcus
          4. Coccidioides Immitis
          5. Zygomycetes
          6. Trichophyton
        4. South Africa Anti-Fungal Treatment Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Dermatology Clinics
      9. Egypt Anti-Fungal Treatment Market
        1. Egypt Anti-Fungal Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Azoles
          2. Echinocandins
          3. Polyenes
          4. Allylamines
          5. Pyrimidines
        2. Egypt Anti-Fungal Treatment Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Systemic
          2. Candidiasis
          3. Cryptococcosis
          4. Prophylactic Use of Antifungals
          5. Coccidioidomycosis
        3. Egypt Anti-Fungal Treatment Market By Pathogens 2022-2034 (USD MILLION/ Units)
          1. Candida
          2. Aspergillus
          3. Cryptococcus
          4. Coccidioides Immitis
          5. Zygomycetes
          6. Trichophyton
        4. Egypt Anti-Fungal Treatment Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Dermatology Clinics
      10. Nigeria Anti-Fungal Treatment Market
        1. Nigeria Anti-Fungal Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Azoles
          2. Echinocandins
          3. Polyenes
          4. Allylamines
          5. Pyrimidines
        2. Nigeria Anti-Fungal Treatment Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Systemic
          2. Candidiasis
          3. Cryptococcosis
          4. Prophylactic Use of Antifungals
          5. Coccidioidomycosis
        3. Nigeria Anti-Fungal Treatment Market By Pathogens 2022-2034 (USD MILLION/ Units)
          1. Candida
          2. Aspergillus
          3. Cryptococcus
          4. Coccidioides Immitis
          5. Zygomycetes
          6. Trichophyton
        4. Nigeria Anti-Fungal Treatment Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Dermatology Clinics
      11. Rest of MEA Anti-Fungal Treatment Market
        1. Rest of MEA Anti-Fungal Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Azoles
          2. Echinocandins
          3. Polyenes
          4. Allylamines
          5. Pyrimidines
        2. Rest of MEA Anti-Fungal Treatment Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Systemic
          2. Candidiasis
          3. Cryptococcosis
          4. Prophylactic Use of Antifungals
          5. Coccidioidomycosis
        3. Rest of MEA Anti-Fungal Treatment Market By Pathogens 2022-2034 (USD MILLION/ Units)
          1. Candida
          2. Aspergillus
          3. Cryptococcus
          4. Coccidioides Immitis
          5. Zygomycetes
          6. Trichophyton
        4. Rest of MEA Anti-Fungal Treatment Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Dermatology Clinics
    5. LATAM
      1. LATAM Anti-Fungal Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
      2. LATAM Anti-Fungal Treatment Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Systemic
        2. Candidiasis
        3. Cryptococcosis
        4. Prophylactic Use of Antifungals
        5. Coccidioidomycosis
      3. LATAM Anti-Fungal Treatment Market By Pathogens 2022-2034 (USD MILLION/ Units)
        1. Candida
        2. Aspergillus
        3. Cryptococcus
        4. Coccidioides Immitis
        5. Zygomycetes
        6. Trichophyton
      4. LATAM Anti-Fungal Treatment Market By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Dermatology Clinics
      5. Brazil Anti-Fungal Treatment Market
        1. Brazil Anti-Fungal Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Azoles
          2. Echinocandins
          3. Polyenes
          4. Allylamines
          5. Pyrimidines
        2. Brazil Anti-Fungal Treatment Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Systemic
          2. Candidiasis
          3. Cryptococcosis
          4. Prophylactic Use of Antifungals
          5. Coccidioidomycosis
        3. Brazil Anti-Fungal Treatment Market By Pathogens 2022-2034 (USD MILLION/ Units)
          1. Candida
          2. Aspergillus
          3. Cryptococcus
          4. Coccidioides Immitis
          5. Zygomycetes
          6. Trichophyton
        4. Brazil Anti-Fungal Treatment Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Dermatology Clinics
      6. Mexico Anti-Fungal Treatment Market
        1. Mexico Anti-Fungal Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Azoles
          2. Echinocandins
          3. Polyenes
          4. Allylamines
          5. Pyrimidines
        2. Mexico Anti-Fungal Treatment Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Systemic
          2. Candidiasis
          3. Cryptococcosis
          4. Prophylactic Use of Antifungals
          5. Coccidioidomycosis
        3. Mexico Anti-Fungal Treatment Market By Pathogens 2022-2034 (USD MILLION/ Units)
          1. Candida
          2. Aspergillus
          3. Cryptococcus
          4. Coccidioides Immitis
          5. Zygomycetes
          6. Trichophyton
        4. Mexico Anti-Fungal Treatment Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Dermatology Clinics
      7. Argentina Anti-Fungal Treatment Market
        1. Argentina Anti-Fungal Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Azoles
          2. Echinocandins
          3. Polyenes
          4. Allylamines
          5. Pyrimidines
        2. Argentina Anti-Fungal Treatment Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Systemic
          2. Candidiasis
          3. Cryptococcosis
          4. Prophylactic Use of Antifungals
          5. Coccidioidomycosis
        3. Argentina Anti-Fungal Treatment Market By Pathogens 2022-2034 (USD MILLION/ Units)
          1. Candida
          2. Aspergillus
          3. Cryptococcus
          4. Coccidioides Immitis
          5. Zygomycetes
          6. Trichophyton
        4. Argentina Anti-Fungal Treatment Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Dermatology Clinics
      8. Chile Anti-Fungal Treatment Market
        1. Chile Anti-Fungal Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Azoles
          2. Echinocandins
          3. Polyenes
          4. Allylamines
          5. Pyrimidines
        2. Chile Anti-Fungal Treatment Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Systemic
          2. Candidiasis
          3. Cryptococcosis
          4. Prophylactic Use of Antifungals
          5. Coccidioidomycosis
        3. Chile Anti-Fungal Treatment Market By Pathogens 2022-2034 (USD MILLION/ Units)
          1. Candida
          2. Aspergillus
          3. Cryptococcus
          4. Coccidioides Immitis
          5. Zygomycetes
          6. Trichophyton
        4. Chile Anti-Fungal Treatment Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Dermatology Clinics
      9. Colombia Anti-Fungal Treatment Market
        1. Colombia Anti-Fungal Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Azoles
          2. Echinocandins
          3. Polyenes
          4. Allylamines
          5. Pyrimidines
        2. Colombia Anti-Fungal Treatment Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Systemic
          2. Candidiasis
          3. Cryptococcosis
          4. Prophylactic Use of Antifungals
          5. Coccidioidomycosis
        3. Colombia Anti-Fungal Treatment Market By Pathogens 2022-2034 (USD MILLION/ Units)
          1. Candida
          2. Aspergillus
          3. Cryptococcus
          4. Coccidioides Immitis
          5. Zygomycetes
          6. Trichophyton
        4. Colombia Anti-Fungal Treatment Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Dermatology Clinics
      10. Rest of LATAM Anti-Fungal Treatment Market
        1. Rest of LATAM Anti-Fungal Treatment Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Azoles
          2. Echinocandins
          3. Polyenes
          4. Allylamines
          5. Pyrimidines
        2. Rest of LATAM Anti-Fungal Treatment Market By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
          1. Systemic
          2. Candidiasis
          3. Cryptococcosis
          4. Prophylactic Use of Antifungals
          5. Coccidioidomycosis
        3. Rest of LATAM Anti-Fungal Treatment Market By Pathogens 2022-2034 (USD MILLION/ Units)
          1. Candida
          2. Aspergillus
          3. Cryptococcus
          4. Coccidioides Immitis
          5. Zygomycetes
          6. Trichophyton
        4. Rest of LATAM Anti-Fungal Treatment Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Clinics
          2. Dermatology Clinics
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.